product summary
Loading...
company name :
R&D Systems
product type :
antibody
product name :
Goat IgG Antibody (GT175) [Alexa Fluor® 350]
catalog :
NBP2-50413AF350
quantity :
0.1 ml
price :
469 USD
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
GT175
application :
immunohistochemistry
more info or order :
product information
brand :
Novus
master code :
NBP2-50413AF350
SKU :
NBP2-50413AF350
product name :
Goat IgG Antibody (GT175) [Alexa Fluor® 350]
sizes available :
0.1 ml
description :
The Goat IgG Antibody (GT175) [Alexa Fluor® 350] from NBP2-50413AF350 is a 6.3e-05 antibody to . This antibody reacts with goat.
target :
Goat IgG
category :
Primary Antibodies
buffer :
50mM Sodium Borate
clonality :
Monoclonal
clone :
GT175
conjugate :
Alexa Fluor 350
all_available conjugate :
PE;Janelia Fluor 525;Alexa Fluor 488;Alexa Fluor 350
dilution :
Immunohistochemistry
host :
Mouse
immunogen :
Goat immunoglobulins
isotype :
IgG1
purity :
Protein A purified
species :
Goat
applications :
Immunohistochemistry
USD :
469 USD
alt names :
Immunoglobulin G
storage :
Store at 4C in the dark.
more info or order :
company information

R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.
browse more products
- CD200R1 Antibody (OX108) [Allophycocyanin/Cy7] - Chimeric | NBP2-52642APCCY7
- CD8 Antibody (V44P1H9*F11) [Alexa Fluor® 700] | NBP2-50152AF700
- RSV Fusion Protein Antibody (RSHZ19 (Felvizumab)) [Alexa Fluor® 594] | NBP2-75191AF594
- RSV Fusion Protein Antibody (RSHZ19 (Felvizumab)) [Alexa Fluor® 647] | NBP2-75191AF647
- RSV Fusion Protein Antibody (RSHZ19 (Felvizumab)) [Alexa Fluor® 700] | NBP2-75191AF700
questions and comments
